CompoAtlas

Candovits

Food supplement declared in France, declaration No 2023-7-388

Candovits (LEPIVITS) is a food supplement declared in France. Status: retiré du marché le 1 March 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
LEPIVITS
Food business operator placing the product on the market
LEPIVITS SA
Status
Retiré du marché le 1 March 2026
Form
Gélule
Daily dose
2 gélules par jour
Directions for use
Avaler 2 gélules par jour, aux repas avec un verre d’eau
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Problèmes cardiaques, Problèmes de foie, Sous anticoagulants, Sous antidiabétiques, Sous traitement médicamenteux
Objectives stated by the manufacturer (these are not authorised claims)
Antioxydant, Transit, Immunité

Declaration 240125, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Citrus paradisi Macfad.PépinExtrait sec hydroalcoolique300 mg
Olea europaea subsp. europaeaFeuilleExtrait sec hydroalcoolique250 mg
Origanum vulgare L.FeuilleExtrait sec aqueux200 mg
Allium sativum L.BulbeExtrait sec aqueux100 mg
Berberis vulgaris L.RacineExtrait sec hydroalcoolique100 mg

Other active ingredients

NamePer day
Caprylate de calciumnot declared
Propolisnot declared
Citroflavonoïdesnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg

Additives

E570, E1204, E322

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Consultez votre médecin ou votre pharmacien en cas d’usage concomitant d’anticoagulants. La consommation de berbérine est déconseillée aux populations identifiées comme étant à risque : femmes enceintes et allaitantes, enfants et adolescents, personnes diabétiques, personnes présentant un trouble cardiaque ou hépatique. Ne pas dépasser la dose journalière recommandée. Un complément alimentaire ne se substitue pas à un régime alimentaire varié et équilibré et à un mode de vie sain. Un complément alimentaire n'est pas un médicament. Tenir hors de la portée des enfants. Conserver à l'abri de la lumière et de l'humidité.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : LEPIVITS

Enter to analyse, Shift+Enter for a new line